Drug Manufacturers - Specialty & Generic Industry | Healthcare Sector | Ms. Yingzi Zeng CEO | XSHE Exchange | CNE000001QB8 ISIN |
CN Country | 1,353 Employees | - Last Dividend | 29 May 2020 Last Split | 24 Jan 2007 IPO Date |
Founded in 2003 and headquartered in Weifang, China, Shandong Wohua Pharmaceutical Co., Ltd. is a leading provider of pharmaceutical products within the Chinese healthcare sector. Operating as a key subsidiary of Beijing Zhongzheng Wanrong Investment Group Co., Ltd., Wohua Pharmaceutical has established itself as a stalwart in the research, development, manufacture, and sale of a wide range of pharmaceutical formulations and medical solutions. The company's comprehensive portfolio includes tablets, capsules, granules, powders, and various types of pills, alongside oral liquids and other medicinal forms. In addition to its extensive product range, Wohua Pharmaceutical offers specialized medical technology consulting services, further contributing to its status as a comprehensive healthcare provider. With a strong commitment to addressing cardiovascular and cerebrovascular diseases, musculoskeletal disorders, urinary system diseases, pediatric illnesses, skin diseases, and more, Wohua continues to innovate and expand its offerings to meet the evolving needs of patients across different therapeutic areas.
Shandong Wohua Pharmaceutical Co., Ltd.'s rich product portfolio caters to a wide array of health conditions, leveraging advanced pharmaceutical technologies and practices. Here is a closer look at some of their key products and services: